Scott Caveney - Publications, H-index & Citations

Scott Caveney

AstraZeneca

8H指数

34论文数

325被引数

收录论文 12

发表时间

Thymic stromal lymphopoietin as a therapeutic target in patients with chronic rhinosinusitis and nasal polyps 胸腺基质淋巴细胞生成素作为慢性鼻窦炎伴鼻息肉患者的治疗靶点

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2025-01-01

OAAI

Peters, Anju T.; Han, Joseph K.; Heffler, Enrico; McClenahan, Freyja; Caveney, Scott; Le, Tham T.; Megally, Ayman; Spahn, Joseph D.; Foster, Andrew; Sherrill, Joseph D.

Predicting Asthma Exacerbations Using Machine Learning Models 使用机器学习模型预测哮喘恶化

ADVANCES IN THERAPY

IF4

2024-11-18

OAAI

Turcatel, Gianluca; Xiao, Yi; Caveney, Scott; Gnacadja, Gilles; Kim, Julie; Molfino, Nestor A.

Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps

ADVANCES IN THERAPY

IF4

2024-11-08

OAAI

Jacobs, Joshua S.; Han, Joseph K.; Lee, Jason K.; Laidlaw, Tanya M.; Martin, Nicole L.; Caveney, Scott; Ambrose, Christopher S.; Martin, Neil; Spahn, Joseph D.; Hoyte, Flavia C. L.

Oral and inhaled corticosteroid dose reductions with tezepelumab versus placebo in patients with severe, uncontrolled asthma from

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2024-11-01

OAAI

Wechsler, Michael E.; Stolz, Daiana; Lugogo, Njira L.; Caveney, Scott; Almqvist, Gun; Bednarczyk, Artur; Kotalik, Ales; Chandarana, Shradha; Ambrose, Christopher S.

Inhaled corticosteroid dose reduction with tezepelumab in patients with severe, uncontrolled asthma over 2 years tezepelumab在2年以上重度未控制哮喘患者中减少吸入皮质类固醇剂量

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-27

PREAI

Stolz, Daiana; Lugogo, Njira; Lawson, Kaitlyn; Colice, Gene; Ponnarambil, Sandhia; Caveney, Scott; Chandarana, Shradha; Cook, Bill

Biomarkers and clinical outcomes after cessation of tezepelumab after 2 years of treatment (DESTINATION)Biomarkers and clinical outcomes after cessation of tezepelumab after 2 years of treatment (DESTINATION)

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-27

PREAI

Brightling, Christopher E.; Jackson, David; Kotalik, Ales; Molfino, Nestor A.; Caveney, Scott; Colice, Gene; Martin, Neil; Israel, Elliot; Pavord, Ian D.; Wechsler, Michael E.; Porsbjerg, Celeste

MACHINE LEARNING MODELS TO PREDICT ASTHMA EXACERBATIONS

CHEST

IF8.6

2023-10-01

OAAI

Turcatel, Gianluca; Xiao, Yi; Caveney, Scott; Gnacadja, Gilles; Kim, Julie; Molfino, Nestor

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR (vol 16, pg 915, 2023)

JOURNAL OF ASTHMA AND ALLERGY

IF3

2023-09-01

OAAI

Laidlaw, Tm; Menzies-Gow, A.; Caveney, S.

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR

JOURNAL OF ASTHMA AND ALLERGY

IF3

2023-09-01

OAAI

Laidlaw, Tanya M.; Menzies-Gow, Andrew; Caveney, Scott; Han, Joseph K.; Martin, Nicole; Israel, Elliot; Lee, Jason K.; Llanos, Jean-Pierre; Martin, Neil; Megally, Ayman; Parikh, Bhavini; Vong, Sylvia; Welte, Tobias; Corren, Jonathan

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

LANCET RESPIRATORY MEDICINE

IF32.8

2023-05-01

OAAI

Menzies-Gow, Andrew; Wechsler, Michael E.; Brightling, Christopher E.; Korn, Stephanie; Corren, Jonathan; Israel, Elliot; Chupp, Geoffrey; Bednarczyk, Artur; Ponnarambil, Sandhia; Caveney, Scott; Almqvist, Gun; Golabek, Monika; Simonsson, Linda; Lawson, Kaitlyn; Bowen, Karin; Colice, Gene

EFFECT OF AGE ON EFFICACY AND SAFETY OF ONCE-DAILY UMECLIDINIUM IN PATIENTS WITH COPD

CHEST

IF8.6

2018-10-01

PREAI

Soule, Tedi; Caveney, Scott; Tombs, Lee; Naya, Ian; Boucot, Isabelle

AN EVALUATION OF PATIENT AGE ON THE EFFICACY AND SAFETY OF ONCE DAILY FLUTICASONE FUROATE/VILANTEROL 100/25 IN COPD FROM TWO LUNG FUNCTION TRIALS

CHEST

IF8.6

2018-10-01

PREAI

Caveney, Scott; Kline, Glaxo Smith; Soule, Tedi; Lettis, Sally; Crim, Courtney

研究方向